L'ophtalmologie à l'officine

Les demandes de conseils dans le domaine ophtalmologique sont fréquentes à l officine. Cette thèse de Pharmacie a été réalisée dans le but de faciliter la démarche du pharmacien dans son rôle de conseil et d orientation du patient, notamment en ce qui concerne la bonne observance des traitements prescrits. Dans un premier temps, quelques rappels anatomo-physiologiques sont présentés afin de mieux appréhender les différentes pathologies oculaires. Puis, selon les symptômes, les pathologies oculaires aiguës sont décrites avec, à chaque fois, le rôle du pharmacien face à de telles situations. Par la suite, les pathologies ophtalmologiques chroniques sont abordées avec leur(s) traitement(s) afin de mieux conseiller le patient lors de la délivrance d une ordonnance. Des tableaux récapitulatifs des différents traitements ophtalmologiques sont présentés avec les principaux effets indésirables et conseils associés. Enfin, différents cas de comptoir fréquents sont décrits ainsi que leur prise en charge officinale. En annexe, des fiches conseils permettent de rappeler les caractéristiques essentielles des pathologies les plus courantes et les solutions officinales à y apporter.ROUEN-BU Médecine-Pharmacie (765402102) / SudocSudocFranceF

Impact of new lamellar techniques of keratoplasty on eye bank activity

Abstract Background Deep anterior lamellar keratoplasty (DALK) has become an increasingly popular alternative to penetrating keratoplasty in patients with stromal corneal pathologies. The main advantages of DALK are: prevention of long-term endothelial loss, elimination of allograft reaction and short topical steroid treatment with lower risks of glaucoma, cataract and infection. Because this technique enables surgeons to use corneal grafts with low endothelial density, the aim of this paper was to determine whether this type of innovation has had a significant impact on eye bank activity. Methods We reviewed our corneal graft activity over a 40-month period and assessed the proportion of deep lamellar and penetrating keratoplasties. During the same period, we also evaluated our eye bank activity and recorded the utilisation of grafts with endothelium abnormalities, which were only suitable for lamellar techniques. Results Deep lamellar keratoplasty represented 29.8% (85 out of 285) of corneal transplantations. Forty-eight percent of all corneas stored at the local eye bank were unsuitable for penetrating keratoplasty; 36.6% of those were not suitable for endothelial deficiencies. Among these, 72.7% were used for DALK and 27.3% were rejected. This permitted a 24.5% increase in corneal grafting activity. In contrast, Descemet's membrane was removed at the time of surgery in 12% of corneas with healthy endothelium, which was used for deep lamellar keratoplasty. Conclusions Deep anterior lamellar keratoplasty development and close collaboration between eye banks and surgeons can induce a significant increase in corneal grafting. This could be a partial solution in countries confronted with corneal graft shortages

Incidence of postoperative nosocomial endophthalmitis: results of an eight-year prospective surveillance programme in a university hospital in France

International audienc

Spontaneous Intracerebral Hematoma from Transient Occult Carotid-cavernous Fistula : A Case Report

After the spontaneous relief of initial symptoms by traumatic carotid-cavernous fistula (CCF), paradoxical worsening of patient's condition can be followed. We present a case of a 60-yr-old man whose audible bruit from a traumatic CCF had completely disappeared. A few days later, however, the patient had spontaneous intracerebral hematoma with cortical venous drainage. Complete obliteration of the fistula was achieved after embolization. When initial audible bruit in traumatic CCF disappears suddenly, cerebral angiography should be performed to differentiate venous hypertension by the hemodynamic changes of the cavernous sinus channels from spontaneous resolution of CCF

Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis

International audienceBackground: Acanthamoeba keratitis (AK) is a sight-threatening infectious disease. Its effective and safe medical therapy remains highly debated. Recently, voriconazole, a monotriazole with noted in vitro activity against a large variety of fungi, has been successfully used both topically and systemically to treat human AK cases.Objectives: To measure anti-Acanthamoeba polyphaga in vitro activity, anti-rat AK efficiency and rat cornea penetration of eye-drop and oral voriconazole.Methods: A. polyphaga was maintained in axenic cultures. In vitro, amoebicidal and cysticidal activities of voriconazole were measured using an XTT assay. AK lesions of Sprague Dawley rats were scored from grade 0 to grade 3. For 21 days, from day 7 post-infection, voriconazole (1% solution) eye drops were instilled or voriconazole was administered by gavage (60 mg/kg/day). After killing, superficial corneal epithelium scrapings were cultured and analysed by PCR, and eye-globe histology was performed. Cornea and plasma concentrations were determined using 2D HPLC separation and tandem MS.Results: In vitro, voriconazole inhibited trophozoite proliferation with an IC50 value of 0.02 mg/L and an IC90 value of 2.86 mg/L; no cysticidal effect was found. In AK rats, eye drops reduced clinical worsening from day 7 to day 14 post-infection and oral voriconazole was not effective. Voriconazole cornea concentrations were directly dependent on the frequency of eye-drop instillations, which resulted in lower plasma concentrations, whilst oral voriconazole resulted in lower cornea concentrations.Conclusions: Present data underline the need for high-frequency eye-drop instillation regimens for efficient AK therapy

The “Yogurt” Technique for Descemet Membrane Endothelial Keratoplasty Graft Preparation: A Novel Quick and Safe Method for Both Inexperienced and Senior Surgeons

PURPOSE:To describe and evaluate the efficacy and safety of a novel technique to prepare Descemet membrane endothelial keratoplasty (DMEK) donor grafts using a newly designed partial-thickness hinge punch. METHODS:The novel punch has a circular guarded blade missing 1 clock hour, creating an uncut hinge on the donor cornea. In addition, 2 straight cuts are made by the punch perpendicular to the edge of trephination toward the trabecular meshwork in the hinge area. After the donor corneoscleral rim is positioned endothelial side up, a partial-thickness trephination is performed avoiding any rotational movements. Descemet membrane is lifted from Schwalbe line in the hinge area, and DMEK graft is peeled after desired marking without further preparation. RESULTS:Three surgeons of different experience levels on DMEK (senior/independent/fellow) initially applied the new technique in 18 research corneas, divided into equal groups. Two failures in graft preparation were noted, defined as radial tears extending ≥0.5 mm. The mean preparation time was 6.21 ± 1.45 minutes. No statistically significant differences were noted in success rate, duration, and endothelial cell loss (ECL) between surgeons (P > 0.05). ECL was evaluated as an average of 5 readings on randomly selected graft areas, not including graft periphery. Fifteen additional research corneas were stripped by 1 single user in an eye bank setting. No tissue loss was recorded, whereas ECL and mortality rate remained unaffected after preparation (P = 0.64 and P = 0.72, respectively). CONCLUSIONS:This new DMEK graft preparation technique, simulating the opening of a yogurt cup, seems to be a safe and an efficient method, providing shorter preparation time and low failure rates independent of surgeon's experience level

Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis

BACKGROUND: Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS). In recent years, it has been found that cells such as human amnion epithelial cells (hAECs) have the ability to modulate immune responses in vitro and in vivo and can differentiate into multiple cell lineages. Accordingly, we investigated the immunoregulatory effects of hAECs as a potential therapy in an MS-like disease, EAE (experimental autoimmune encephalomyelitis), in mice. METHODS: Using flow cytometry, the phenotypic profile of hAECs from different donors was assessed. The immunomodulatory properties of hAECs were examined in vitro using antigen-specific and one-way mixed lymphocyte proliferation assays. The therapeutic efficacy of hAECs was examined using a relapsing-remitting model of EAE in NOD/Lt mice. T cell responsiveness, cytokine secretion, T regulatory, and T helper cell phenotype were determined in the peripheral lymphoid organs and CNS of these animals. RESULTS: In vitro, hAECs suppressed both specific and non-specific T cell proliferation, decreased pro-inflammatory cytokine production, and inhibited the activation of stimulated T cells. Furthermore, T cells retained their naïve phenotype when co-cultured with hAECs. In vivo studies revealed that hAECs not only suppressed the development of EAE but also prevented disease relapse in these mice. T cell responses and production of the pro-inflammatory cytokine interleukin (IL)-17A were reduced in hAEC-treated mice, and this was coupled with a significant increase in the number of peripheral T regulatory cells and naïve CD4+ T cells. Furthermore, increased proportions of Th2 cells in the peripheral lymphoid organs and within the CNS were observed. CONCLUSION: The therapeutic effect of hAECs is in part mediated by inducing an anti-inflammatory response within the CNS, demonstrating that hAECs hold promise for the treatment of autoimmune diseases like MS

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

Introduction: The current practice of quantifying cerebrospinal fluid (CSF) biomarkers as an aid in the diagnosis of Alzheimer's disease (AD) varies from center to center. For a same biochemical profile, interpretation and reporting of results may differ, which can lead to misunderstandings and raises questions about the commutability of tests. Methods: We obtained a description of (pre-)analytical protocols and sample reports from 40 centers worldwide. A consensus approach allowed us to propose harmonized comments corresponding to the different CSF biomarker profiles observed in patients. Results: The (pre-)analytical procedures were similar between centers. There was considerable heterogeneity in cutoff definitions and report comments. We therefore identified and selected by consensus the most accurate and informative comments regarding the interpretation of CSF biomarkers in the context of AD diagnosis. Discussion: This is the first time that harmonized reports are proposed across worldwide specialized laboratories involved in the biochemical diagnosis of AD